OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: Results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial

Retrovirology

Volumn 6, Issue SUPPL. 3, 2009, Pages

  Salmon Ceron D ^a,c   Durier, C ^b   Desaint, C ^a   Cuzin, ^d   Surenaud, M ^e   Henin Y ^a   Lelievre J ^f   Bonnet, B ^g   Pialoux, G ^h   Poizot Martin, I ⁱ   Ben Hamouda, N ^e   Jackson, A ^e   Flys, C ^e   Guerin C ^a   Aboulker, J ^b   Choppin, J ^e   Launay, O ^a  

^a Institut Cochin   (France)

^b INSERM   (France)

^c AP HP   (France)

^d CHU PURPAN   (France)

^e INSTITUT COCHIN   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g HÔTEL DIEU   (France)

^h HÔPITAL TENON   (France)

ⁱ HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449641259     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-S3-O25     Document Type: Note

References (0)